96
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Onset of pain relief with rofecoxib in chronic low back pain: results of two four-week, randomized, placebo-controlled trials

, , &
Pages 651-658 | Accepted 22 Dec 2004, Published online: 12 Mar 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ciaran Williams, Mark J Hancock, Manuela Ferreira, Paulo Ferreira & Chris G Maher. (2012) A literature review reveals that trials evaluating treatment of non-specific low back pain use inconsistent criteria to identify serious pathologies and nerve root involvement. Journal of Manual & Manipulative Therapy 20:2, pages 59-65.
Read now
Bart Morlion. (2011) Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components. Current Medical Research and Opinion 27:1, pages 11-33.
Read now
Shin Chung, Kyung Min Lim & Song Seok Shin. (2005) Profiles of COX-2 inhibitors: present and future. Expert Opinion on Therapeutic Patents 15:1, pages 9-32.
Read now

Articles from other publishers (13)

Kurt T. Hegmann, Russell Travis, Gunnar B.J. Andersson, Roger M. Belcourt, Eugene J. Carragee, Ronald Donelson, Marjorie Eskay-Auerbach, Jill Galper, Michael Goertz, Scott Haldeman, Paul D. Hooper, James E. Lessenger, Tom Mayer, Kathryn L. Mueller, Donald R. Murphy, William G. Tellin, Matthew S. Thiese, Michael S. Weiss & Jeffrey S. Harris. (2020) Non-Invasive and Minimally Invasive Management of Low Back Disorders. Journal of Occupational & Environmental Medicine 62:3, pages e111-e138.
Crossref
K. Janarthanan & S. Adalarasan. (2019) Cox-2 inhibitors in mandibular third molar surgery. Journal of Medicine and Life 12:2, pages 150-155.
Crossref
Gustavo C Machado, Chris G Maher, Paulo H Ferreira, Richard O Day, Marina B Pinheiro & Manuela L Ferreira. (2017) Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis. Annals of the Rheumatic Diseases 76:7, pages 1269-1278.
Crossref
. (2013) Lombalgia inespecífica crônica: reabilitação. Revista da Associação Médica Brasileira 59:6, pages 536-553.
Crossref
Alan J. Kivitz, Joseph S. Gimbel, Candace Bramson, Mary Anne Nemeth, David S. Keller, Mark T. Brown, Christine R. West & Kenneth M. Verburg. (2013) Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain. Pain 154:7, pages 1009-1021.
Crossref
Gerard A. Malanga & Erin T. Wolff. 2012. Evidence-Based Management of Low Back Pain. Evidence-Based Management of Low Back Pain 134 153 .
Pepijn D. D. M. Roelofs, Rick A. Deyo, Bart W. Koes, Rob J. P. M. Scholten & Maurits W. van Tulder. (2008) Nonsteroidal Anti-Inflammatory Drugs for Low Back Pain. Spine 33:16, pages 1766-1774.
Crossref
Pepijn DDM Roelofs, Rick A Deyo, Bart W Koes, Rob JPM Scholten & Maurits W van Tulder. (2008) Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database of Systematic Reviews 2011:2.
Crossref
Gerard Malanga & Erin Wolff. (2008) Evidence-informed management of chronic low back pain with nonsteroidal anti-inflammatory drugs, muscle relaxants, and simple analgesics. The Spine Journal 8:1, pages 173-184.
Crossref
Li‐Chia Chen & Darren M Ashcroft. (2007) Risk of myocardial infarction associated with selective COX‐2 inhibitors: Meta‐analysis of randomised controlled trials. Pharmacoepidemiology and Drug Safety 16:7, pages 762-772.
Crossref
Graham Jackson. 2007. Textbook of Interventional Cardiovascular Pharmacology. Textbook of Interventional Cardiovascular Pharmacology 503 513 .
Maruti Ram Gudavalli, Jerrilyn A. Cambron, Marion McGregor, James Jedlicka, Michael Keenum, Alexander J. Ghanayem & Avinash G. Patwardhan. (2005) A randomized clinical trial and subgroup analysis to compare flexion–distraction with active exercise for chronic low back pain. European Spine Journal 15:7, pages 1070-1082.
Crossref
Peter Jüni, Linda Nartey, Stephan Reichenbach, Rebekka Sterchi, Paul A Dieppe & Matthias Egger. (2004) Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. The Lancet 364:9450, pages 2021-2029.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.